{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:39:39Z","timestamp":1792586379101,"version":"4.5.0"},"reference-count":42,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PGPM"],"DOI":"10.2147\/pgpm.s527556","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T11:25:11Z","timestamp":1755948311000},"page":"197-208","source":"Crossref","is-referenced-by-count":2,"title":["The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data"],"prefix":"10.2147","volume":"Volume 18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3515-6043","authenticated-orcid":true,"given":"Nina","family":"Wittwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7120-6378","authenticated-orcid":true,"given":"Christoph","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette","family":"Meyer zu Schwabedissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4067-9401","authenticated-orcid":true,"given":"Samuel","family":"Allemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/S00702-018-1922-0\/","volume":"126","author":"Mostafa","year":"2019","journal-title":"J Neural Transm"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/ph14050487","volume":"14","author":"Hahn","year":"2021","journal-title":"Pharmaceuticals"},{"key":"ref4","first-page":"630","volume":"39","author":"Westervelt","year":"2014","journal-title":"P T"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0140-6736(22)01841-4","volume":"401","author":"Swen","year":"2023","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1515\/CCLM.2003.087","volume":"41","author":"Oscarson","year":"2003","journal-title":"Clin Chem Lab Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1517\/14740338.2012.631910","volume":"11","author":"Magro","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"w13522","DOI":"10.4414\/smw.2012.13522","volume":"142","author":"Oertle","year":"2012","journal-title":"Swiss Med Wkly"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"w13043","DOI":"10.4414\/smw.2010.13043","volume":"140","author":"Bertoli","year":"2010","journal-title":"Swiss Med Wkly"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e0147606","DOI":"10.1371\/journal.pone.0147606","volume":"11","author":"Bucher","year":"2016","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3111\/13696998.2015.1110160","volume":"19","author":"Brixner","year":"2016","journal-title":"J Med Econ"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.3390\/jcm9092890","volume":"9","author":"Klomp","year":"2020","journal-title":"J Clin Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3390\/genes11121509","volume":"11","author":"de Jong","year":"2020","journal-title":"Genes"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/bcpt.13840","volume":"132","author":"Neyshaburinezhad","year":"2023","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1097\/j.pain.0000000000002637","volume":"163","author":"Chanfreau-Coffinier","year":"2022","journal-title":"Pain"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2217\/PGS-2023-0100","volume":"24","author":"Hahn","year":"2023","journal-title":"Pharmacogenomics"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"113202","DOI":"10.1016\/j.biopha.2022.113202","volume":"152","author":"Gloor","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3233\/978-1-61499-759-7-121","volume":"236","author":"Blagec","year":"2017","journal-title":"Stud Health Technol Inform"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/CPT.2350","volume":"110","author":"Whirl-Carrillo","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"ref20","unstructured":"Clinical Pharmacogenetics Implementation Consortium (CPIC). Available from: https:\/\/cpicpgx.org\/. Accessed July 1, 2024."},{"key":"ref21","unstructured":"Dutch Pharmacogenetics Working Group (DPWG). homepage on the Internet. Available from: https:\/\/www.knmp.nl\/dossiers\/farmacogenetica\/pharmacogenetics. Accessed July 1, 2024."},{"key":"ref22","unstructured":"Schur N, Twerenbold S, Reinau D, Schwenkglenks M, Meier CR. 2020. Available from: https:\/\/www.helsana.ch\/de\/helsana-gruppe\/medien-publikationen\/helsana-reports\/arzneimittelreport.html. Accessed September 02, 2024."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1056\/NEJMp1508256","volume":"373","author":"Biller-Andorno","year":"2015","journal-title":"N Engl J Med"},{"key":"ref24","unstructured":"Federal Office of Public Health (FOPH). Specialties List (SL). 2023. Available from: http:\/\/www.spezialit\u00e4tenliste.ch\/. Accessed April 7, 2022."},{"key":"ref25","unstructured":"Federal Office of Public Health (FOPH). Inpatient tariff structures. 2021. Available from: https:\/\/www.bag.admin.ch\/en\/inpatient-tariff-structures. Accessed November 24, 2023."},{"key":"ref26","unstructured":"Helsana. Available from: https:\/\/www.helsana.ch\/de\/helsana-gruppe\/medien-publikationen\/wissenschaftliche-publikationen. Accessed April 8, 2024."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/PGPM.S382214","volume":"15","author":"Wittwer","year":"2022","journal-title":"Pharmgenomics Pers Med"},{"key":"ref28","unstructured":"Flockhart D, Thacker D, McDonald C, Desta Z. The flockhart cytochrome p450 drug-drug interaction table. division of clinical pharmacology, Indiana university school of medicine (Updated 2021). Available from: https:\/\/drug-interactions.medicine.iu.edu. Accessed March 6, 2024."},{"key":"ref29","unstructured":"U.S. Food & Drug Administration (FDA). For Healthcare Professionals | FDA\u2019s Examples of Drugs that Interact with CYP Enzymes and Transporter Systems. 2023. Available from: https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems. Accessed April 10, 2024."},{"key":"ref30","unstructured":"Centre d\u2019informations th\u00e9rapeutique et de pharmacovigilance Service de pharmacologie et toxicologie cliniques, H\u00f4pitaux Universitaires 1211 Gen\u00e8ve 14. INTERACTIONS MEDICAMENTEUSES, CYTOCHROMES P450 ET P-GLYCOPROTEINE (Pgp). 2020. Available from: https:\/\/www.hug.ch\/sites\/interhug\/files\/structures\/pharmacologie_et_toxicologie_cliniques\/a5_cytochromes_6_2.pdf. Accessed March 6, 2024."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"52:D1265","DOI":"10.1093\/nar\/gkad976","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"ref32","unstructured":"Fedlex. Federal Act on Data Protection (FADP). 2019. Available from: https:\/\/www.fedlex.admin.ch\/eli\/cc\/1993\/1945_1945_1945\/en. Accessed December 24, 2021."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"724170","DOI":"10.3389\/fpsyt.2021.724170","volume":"12","author":"Mostafa","year":"2021","journal-title":"Front Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"566","DOI":"10.37765\/ajmc.2022.89259","volume":"28","author":"Dowd","year":"2022","journal-title":"Am J Manag Care"},{"key":"ref35","unstructured":"Schweizerisches Gesundheitsobservatorium. Psychopharmaka in der Schweiz. Obs Bull. 2022;01. Available from: www.obsan.admin.ch\/de\/. Accessed October 10, 2022."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/JPM10030078","volume":"10","author":"Vermehren","year":"2020","journal-title":"J Pers Med"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1177\/009286150503900308","volume":"39","author":"Neutel","year":"2005","journal-title":"Drug Inf J"},{"key":"ref38","unstructured":"refdata. Medicinal product information. Available from: https:\/\/www.swissmedicinfo.ch\/. Accessed August 12, 2023."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bcp.2014.11.011","volume":"93","author":"Okubo","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/FTD.0b013e318283b49a","volume":"35","author":"Yamamoto","year":"2013","journal-title":"Ther Drug Monit"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/cpt.1135","volume":"104","author":"Monte","year":"2018","journal-title":"Clin Pharmacol Ther"}],"container-title":["Pharmacogenomics and Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/106100","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/106100","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T11:25:14Z","timestamp":1755948314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/the-prevalence-of-potential-drug-drug-gene-interactions-a-descriptive--peer-reviewed-fulltext-article-PGPM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":42,"URL":"https:\/\/doi.org\/10.2147\/pgpm.s527556","relation":{},"ISSN":["1178-7066"],"issn-type":[{"value":"1178-7066","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]}}}